EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alteration in sB7-H4 Serum Levels and Placental Biomarker Expression after Therapeutic Plasma Exchange in Early-Onset Preeclampsia Patients

Liyan Duan, Yuyang Ma, Beatrix Reisch, Elina Hadrovic, Pawel Mach, Rainer Kimmig, Michael Jahn iD, Angela Köninger, Antonella Iannaccone iD, Alexandra Gellhaus iD

International Journal of Molecular Sciences · 15.10.2024 · 25 (20) · 11082

DOI: 10.3390/ijms252011082 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.10.2024. Verfasst von Liyan Duan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, University of Duisburg-Essen, 45147 Essen, Germany. Hauptthemen laut MEDLINE: Pre-Eclampsia, Biomarkers, V-Set Domain-Containing T-Cell Activation Inhibitor 1, Placenta. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, Open Access Publication Fund of the University of Duisburg-Essen, China Scholarship Council (CSC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Therapeutic plasma exchange (TPE) is a widely used treatment for numerous diseases including pregnancy-related conditions. Our prior study on 20 early-onset preeclampsia patients undergoing TPE revealed a significant extension in pregnancy duration and reduced serum levels of sFlt-1, sFlt-1/PlGF, and sEndoglin. Here, we investigated the impact of TPE on serum sB7-H4, an immunological checkpoint molecule, and placental proteins (Flt-1, Eng, B7-H4, iNOS, TNF-α) in TPE-treated early-onset preeclampsia patients (N = 12, 23 + 2–28 + 5 weeks), conventionally treated counterparts (N = 12, 23 + 5–30 weeks), and gestational age-matched controls (N = 8, 22 + 4–31 + 6 weeks). Immunoblotting, ELISA, and co-immunohistochemistry were used for biomarker analysis, including placental inflammation factors (iNOS, TNF-α). The results showed that TPE extended pregnancy by a median of 6.5 days in this cohort of early-onset preeclampsia. Serum sB7-H4, sFlt-1, and sEndoglin levels decreased, along with reduced expression of their membrane-bound proteins in placental tissue upon TPE treatment. Moreover, TPE-treated patients displayed reduced placental inflammation compared to preeclampsia patients receiving standard-of-care treatment. In conclusion, TPE may improve pregnancy outcomes in early-onset preeclampsia by lowering circulating levels of sB7-H4, sFlt-1, and sEndoglin, as well as reducing placental inflammation. This translational approach holds promise for enhancing placental function and extending gestation in high-risk pregnancies including very preterm PE or HELLP cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaBiomarkersV-Set Domain-Containing T-Cell Activation Inhibitor 1PlacentaVascular Endothelial Growth Factor Receptor-1Plasma ExchangeHumansPregnancyFemaleAdultEndoglinTumor Necrosis Factor-alpha

Stichwörter der Autor:innen

B7-H4placental dysfunctionpreeclampsiapreeclampsia therapypreterm birthsoluble Endoglinsoluble fms-like tyrosine kinase 1therapeutic plasma exchange

Substanzen

BiomarkersV-Set Domain-Containing T-Cell Activation Inhibitor 1VTCN1 protein, humanVascular Endothelial Growth Factor Receptor-1FLT1 protein, humanEndoglinTumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, University of Duisburg-Essen, 45147 Essen, Germany.
  • Department of Nephrology, University of Duisburg-Essen, University Hospital Essen, 45147 Essen, Germany.
  • Department of Gynecology and Obstetrics, University Clinic St. Hedwig of the Order of St. John, 93049 Regensburg, Germany.

ORCID-Profile: Michael Jahn, Antonella Iannaccone, Alexandra Gellhaus

Förderung

  • German Research Foundation
  • Open Access Publication Fund of the University of Duisburg-Essen
  • China Scholarship Council (CSC)

Zitieren

APA

Duan, L., Ma, Y., Reisch, B., Hadrovic, E., Mach, P., Kimmig, R., Jahn, M., Köninger, A., Iannaccone, A., & Gellhaus, A. (2024). Alteration in sB7-H4 Serum Levels and Placental Biomarker Expression after Therapeutic Plasma Exchange in Early-Onset Preeclampsia Patients. International Journal of Molecular Sciences, 25(20), 11082. https://doi.org/10.3390/ijms252011082

Vancouver

Duan L, Ma Y, Reisch B, Hadrovic E, Mach P, Kimmig R, et al. Alteration in sB7-H4 Serum Levels and Placental Biomarker Expression after Therapeutic Plasma Exchange in Early-Onset Preeclampsia Patients. International Journal of Molecular Sciences. 2024;25(20):11082. doi:10.3390/ijms252011082

BibTeX
@article{Duan2024,
  author = {Duan, Liyan and Ma, Yuyang and Reisch, Beatrix and Hadrovic, Elina and Mach, Pawel and Kimmig, Rainer and Jahn, Michael and Köninger, Angela and Iannaccone, Antonella and Gellhaus, Alexandra},
  title = {Alteration in sB7-H4 Serum Levels and Placental Biomarker Expression after Therapeutic Plasma Exchange in Early-Onset Preeclampsia Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {20},
  pages = {11082},
  doi = {10.3390/ijms252011082}
}
Kostenlos starten →